Fulford (India) Ltd

Fulford (India) Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Fulford (India) Ltd

₹ 2,362 0.04%
30 Jul 2015
fulfordindia.com
About

Fulford (India) is engaged in the business of trading of Pharmaceuticals.

[ add key points ]
Website
  • Market Cap ₹ Cr.
  • Current Price ₹ 2,362
  • High / Low ₹ /
  • Stock P/E
  • Book Value ₹ 294
  • Dividend Yield 0.00 %
  • ROCE 18.1 %
  • ROE 10.6 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Company has been maintaining a healthy dividend payout of 220%

Cons

  • Stock is trading at 8.03 times its book value
  • The company has delivered a poor sales growth of -14.7% over past five years.
  • Company has a low return on equity of 13.1% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Jun 2013 Sep 2013 Dec 2013 Mar 2014 Jun 2014 Sep 2014 Dec 2014 Mar 2015
46.65 61.48 59.69 55.83 45.99 57.07 64.39 49.14 46.47
54.78 60.05 54.91 53.42 51.12 55.72 56.84 60.33 52.82
Operating Profit -8.13 1.43 4.78 2.41 -5.13 1.35 7.55 -11.19 -6.35
OPM % -17.43% 2.33% 8.01% 4.32% -11.15% 2.37% 11.73% -22.77% -13.66%
2.58 2.45 2.25 2.68 2.58 2.29 2.88 2.17 6.88
Interest 0.01 0.77 0.00 0.04 0.13 0.01 0.01 0.24 -0.07
Depreciation 0.39 0.33 0.28 0.27 0.25 0.21 0.22 0.12 0.05
Profit before tax -5.95 2.78 6.75 4.78 -2.93 3.42 10.20 -9.38 0.55
Tax % -31.93% 33.81% 35.26% 27.20% -60.07% 33.92% 34.22% -31.34% 140.00%
-4.05 1.84 4.37 3.48 -1.17 2.26 6.71 -6.44 -0.22
EPS in Rs -10.38 4.72 11.21 8.92 -3.00 5.79 17.21 -16.51 -0.56
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Dec 2009 Dec 2010 Dec 2011 Dec 2012 Mar 2014 15m Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
184 190 213 213 265 230 155 142 122 100 109 70
167 179 218 228 270 239 182 119 99 79 79 44
Operating Profit 17 11 -5 -15 -5 -9 -27 23 22 21 30 26
OPM % 9% 6% -2% -7% -2% -4% -17% 16% 18% 21% 28% 38%
6 8 9 10 13 14 6 7 7 19 9 5
Interest 0 0 0 0 1 0 0 0 0 0 0 0
Depreciation 1 2 2 2 2 1 0 0 0 0 0 0
Profit before tax 22 17 3 -7 5 5 -21 29 29 39 39 31
Tax % 39% 31% 32% -31% 18% 52% -33% 39% 39% 30% 27% 41%
13 12 2 -5 4 2 -14 18 18 28 28 18
EPS in Rs 34.51 30.92 4.72 -12.79 11.46 5.92 -36.26 45.46 45.72 71.26 72.67 46.36
Dividend Payout % 13% 15% 74% -8% 17% 25% 0% 2% 2% 5% 1% 654%
Compounded Sales Growth
10 Years: -10%
5 Years: -15%
3 Years: -17%
TTM: -36%
Compounded Profit Growth
10 Years: 4%
5 Years: 27%
3 Years: 1%
TTM: -36%
Stock Price CAGR
10 Years: 0%
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: 6%
5 Years: 13%
3 Years: 13%
Last Year: 11%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Dec 2009 Dec 2010 Dec 2011 Dec 2012 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Equity Capital 4 4 4 4 4 4 4 4 4 4 4 4
Reserves 136 146 146 141 144 146 132 150 167 194 222 111
0 0 0 0 0 0 0 0 0 0 0 0
37 42 66 56 59 41 43 52 41 28 29 35
Total Liabilities 177 192 216 201 208 191 179 205 212 227 255 150
6 6 4 3 1 1 1 1 0 0 0 0
CWIP 0 0 0 0 0 0 0 0 0 0 0 0
Investments 15 0 0 0 0 0 0 0 0 0 0 0
156 187 212 198 206 190 177 204 211 226 255 150
Total Assets 177 192 216 201 208 191 179 205 212 227 255 150

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Dec 2009 Dec 2010 Dec 2011 Dec 2012 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
-5 6 11 -27 9 -76 6 17 7 7 4 34
1 18 8 8 10 13 -31 42 -43 -3 70 4
-1 -2 -2 -2 -1 -1 -1 -0 -0 -1 -1 -129
Net Cash Flow -5 22 17 -20 18 -64 -26 58 -36 3 73 -92

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Dec 2009 Dec 2010 Dec 2011 Dec 2012 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Debtor Days 29 22 16 11 4 32 21 26 10 12 59 34
Inventory Days 142 125 145 138 97 175 118 167 117 119 21 121
Days Payable 112 127 160 123 126 68 92 220 217 155 193 222
Cash Conversion Cycle 59 20 1 26 -25 139 47 -27 -90 -25 -113 -67
Working Capital Days 50 52 -2 17 -14 75 9 -13 -20 7 24 -32
ROCE % 17% 12% 2% -5% 4% 3% -15% 20% 18% 22% 18% 18%

Shareholding Pattern

Numbers in percentages

Shareholding pattern is currently not available for this company.

Documents

Announcements

Annual reports